Clinical trial Recruiting at 2 sites Interventional Ages 6 and up

Observation vs Upfront Surgery for Asymptomatic Kidney Stones in Children and Adults

Official title: Observational Approach Versus Surgical Intervention for Stones

Run by Children's Hospital of Philadelphia · NCT07718802 · Data updated 2026-11-12

This trial tests whether watching asymptomatic kidney stones or performing upfront surgery is better for reducing life disruption in patients aged 6 and older.

Quick facts

Study typeInterventional
Ages6 Years and up
SexAll
Enrollment1658 (estimated)
SponsorChildren's Hospital of Philadelphia
Academic / other
Locations4 sites (Irvine, California and 3 other locations)
StatusRecruiting
StartedAugust 17, 2026
Main results expectedMay 31, 2031
Study endsOctober 1, 2032
Registry record updatedOctober 15, 2026
Trial IDNCT07718802 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 6 or older with asymptomatic, non-obstructive kidney stones measuring 4–10 mm.

Probably not a fit

Patients who have symptomatic stones, obstructive disease, or stones outside the 4–10 mm range may not benefit from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Observational Approach versus Surgical Intervention for Asymptomatic Stone (OASIS) trial compares observation with upfront surgical treatment (URS or SWL) for asymptomatic, non-obstructive kidney stones 4–10 mm. It uses randomized assignment to either observation or surgery, with an optional non-randomized observational cohort for those who decline randomization. Outcomes focus on patient-centered measures and life disruption, alongside safety and healthcare utilization. The study is conducted across several U.S. centers with CHOP as lead sponsor and PCORI involvement, aiming to inform personalized management decisions.

Why it matters

Potential benefit: If successful, the trial could clarify which approach minimizes life disruption and helps tailor treatment to patient preferences.

How similar studies have gone: Previous work has explored management options for kidney stones, but robust randomized evidence specifically for asymptomatic stones guiding observation versus upfront surgery is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Individuals age 6 or older
2. Diagnosis of kidney stone disease (nephrolithiasis)
3. Asymptomatic, non-obstructive kidney stones measuring 4 to 10 mm (inclusive)

   * Asymptomatic is defined as the absence of abdominal pain, flank pain, gross hematuria, and nausea and/or vomiting in the last 3 months that in the judgement of the site PI could be attributable to kidney stones.
   * Non-obstructive is defined as a stone in a renal calyx or stones in multiple renal calyces on CT, ultrasound, and/or x-ray obtained within 6 months of screening.
4. Informed consent and if appropriate, child assent.
5. Willingness to be randomized to surgery or observation Note: subjects otherwise eligible who decline randomization may be enrolled in a parallel observational cohort.
6. Fluent in English or Spanish
7. Willingness to be audio- and/or video- recorded during interviews

Exclusion Criteria:

1. Untreated hydronephrosis or caliectasis
2. Pain (e.g., renal colic, abdominal pain) or gross hematuria attributed to kidney stones.
3. Recurrent symptomatic urinary tract infections (≥3 in 12 months or ≥2 in 6 months). A symptomatic urinary tract infection is defined as having at least one bladder or voiding symptom (e.g., frequency, urgency, dysuria) with bacteriuria (≥105 colony forming units/mL of no more than 2 urinary tract pathogens).
4. Stone in the renal pelvis, ureter, bladder or urethra
5. Pregnant females
6. Solitary kidney, transplant kidney, urinary diversion, medullary sponge kidney
7. Anatomic abnormality of the kidney (e.g., horseshoe kidney)
8. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures

Where it's running

  • University of California, Irvine
    Irvine, California, United States
    Recruiting
  • The Children's Hospital of Philadelphia
    Hatboro, Pennsylvania, United States
    Recruiting
  • University of Minnesota
    Minneapolis, Minnesota, United States
    Not yet recruiting
  • Columbia University Medical Center
    New York, New York, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Gregory E Tasian, MD, MSc, MSCE — Children's Hospital of Philadelphia
  • Study coordinator: Rebecca D McCune, BS, MS
  • Email: mccuner@chop.edu
  • Phone: 267-909-6030

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.